SUNNYVALE, Calif., Aug. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.
The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International). In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 62973019.
A live webcast of the call will also be available from the Investor Relations section of the Company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the first quarter of fiscal 2018.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com
Contacts: |
|
Investors: |
Brian Moore, EVC Group, 310-770-0389, [email protected] |
Doug Sherk, EVC Group, 415-652-9100, [email protected] |
|
Media: |
Beth Kaplan |
Public Relations Director, Accuray |
|
408-789-4426 |
|
SOURCE Accuray Incorporated
Share this article